# Mesorectal Microbiome as a Prognostic Factor in Patients With Rectal Cancer

> **NCT04804956** · — · UNKNOWN · sponsor: **University Hospital of Girona Dr. Josep Trueta** · enrollment: 100 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** Stool sample
- **PROCEDURE:** Rectal mucosa sample
- **PROCEDURE:** Mesorectal adipose tissue sample
- **PROCEDURE:** Subcutaneous adipose tissue sample
- **PROCEDURE:** Visceral adipose tissue sample
- **BEHAVIORAL:** Dietary assessment

## Key facts

- **NCT ID:** NCT04804956
- **Lead sponsor:** University Hospital of Girona Dr. Josep Trueta
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804956, "Mesorectal Microbiome as a Prognostic Factor in Patients With Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04804956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*